Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.1550 (-5.41%) ($5.1550 - $5.1550) on Tue. Nov. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.62% (three month average) | RSI | 43 | Latest Price | $5.1550(-5.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -4.2% a day on average for past five trading days. | Weekly Trend | CGEN declines -4.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(73%) ARKG(70%) ARKK(69%) IWO(67%) IBUY(66%) | Factors Impacting CGEN price | CGEN will decline at least -2.31% in a week (0% probabilities). VIXM(-53%) VXX(-36%) UUP(-10%) TLT(-7%) UNG(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.31% (StdDev 4.62%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.55(-246.46%) | Resistance Level | $6.34 | 5 Day Moving Average | $5.97(-13.65%) | 10 Day Moving Average | $6.3(-18.17%) | 20 Day Moving Average | $6.34(-18.69%) | To recent high | -28.1% | To recent low | 0% | Market Cap | $426m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |